30-day FRN

47756

Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices

Place: The Westin Arlington Gateway, 801
N. Glebe Road, Arlington, VA 22203.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, [email protected].
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Stroke Clinical Trials.
Date: November 2, 2017.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–6033, [email protected].
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R13 Review.
Date: November 8, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ernie Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–4056, [email protected].
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Jointly Sponsored T32
Review.
Date: December 7–8, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites by Hilton
Alexandria Old Town, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)

Dated: October 6, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.

60 days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Specimen
Resource Locator, 0925–0703
Reinstatement without Change, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The availability of
specimens and associated data is critical
to increase our knowledge of cancer
biology, and to translate important
research discoveries to clinical
application. The discovery and
validation of cancer prevention markers
require access, by researchers, to quality
clinical biospecimens. In response, to
this need, the National Cancer
Institute’s (NCI) Cancer Diagnosis
Program has developed, and is
expanding, a searchable database:
Specimen Resource Locator (SRL). The
SRL allows scientists in the research
community and the NCI to locate
specimens needed for their research.
The SRL will list all NCI supported
repositories and their links. This
administrative submission is an on-line
form that will collect information to
manage and improve a program and its
resources for the use of all scientists.
This submission does not involve any
analysis.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
105.

[FR Doc. 2017–22142 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Specimen
Resource Locator (NCI)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of October 13, 2017.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
[email protected] or by
fax to (202) 395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Joanne Demchok,
Program Director, Cancer Diagnosis
Program, Division of Cancer Treatment
and Diagnosis, 9609 Medical Center
Drive, Rockville, MD 20892 or call nontoll-free number (240) 276–5959 or
Email your request, including your
address to: [email protected].
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on July 28, 2017 and allowed
SUMMARY:

asabaliauskas on DSKBBXCHB2PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form name

Private Sector ..............................................................
State Government .......................................................
Federal Government ....................................................
Private Sector ..............................................................

Initial Request ........

VerDate Sep<11>2014

18:05 Oct 12, 2017

Jkt 244001

PO 00000

Annual Update .......

Frm 00070

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

70
70
60
20

E:\FR\FM\13OCN1.SGM

1
1
1
1

13OCN1

Average
burden per
response
(in hours)
30/60
30/60
30/60
5/60

Total
burden hours
35
35
30
2

47757

Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent

Form name

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden hours

State Government .......................................................
Federal Government ....................................................

20
10

1
1

5/60
5/60

2
1

Total ......................................................................

250

250

........................

105

Dated: October 6, 2017.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

Dated: October 6, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2017–22156 Filed 10–12–17; 8:45 am]

[FR Doc. 2017–22141 Filed 10–12–17; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

Prospective Grant of Exclusive Patent
License: Devices and Systems For
Treating Valvular Regurgitation

National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
NHLBI Special Emphasis Panel.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

asabaliauskas on DSKBBXCHB2PROD with NOTICES

Number of
respondents

Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Single Site CLTR Review.
Date: November 6, 2017.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Chang Sook Kim, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7188, Bethesda, MD 20892–7924, 301–827–
7940, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)

VerDate Sep<11>2014

18:05 Oct 12, 2017

Jkt 244001

AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

The National Heart, Lung and
Blood Institute (NHLBI), National
Institutes of Health, Department of
Health and Human Services, is
contemplating the grant of an Exclusive
Patent License to Cook Medical
Technologies, LLC, located in
Bloomington, Indiana, to practice the
inventions embodied in the patent
applications listed in the
Supplementary Information section of
this notice.
DATES: Only written comments and/or
applications for a license which are
received by the NHLBI Office of
Technology Transfer and Development
October 30, 2017 will be considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
exclusive patent license should be
directed to: Michael Shmilovich, Esq.,
Senior Licensing and Patent Manager,
31 Center Drive Room 4A29, MSC2479,
Bethesda, MD 20892–2479, phone
number 301–435–5019, or shmilovm@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
following and all continuing U.S. and
foreign patents/patent applications
thereof are the intellectual properties to
be licensed under the prospective
agreement to Cook Medical
Technologies, LLC: NIH Ref. No. E–027–
2013/0 ‘‘Devices And Methods for
Treating Functional Triscupid Valve
SUMMARY:

PO 00000

Frm 00071

Fmt 4703

Sfmt 4703

Regurgitation’’ U.S. Provisional Patent
Application 61/785,652 filed March 14,
2013, International Patent Application
PCT/US2014/025300 filed under the
Patent Cooperation Treaty on March 13,
2014, European Patent Application
14723540.2 having an international
filing date of March 13, 2014, and U.S.
Patent Application 14/776,488 also
having an international filing date of
March 13, 2014. NIH Ref. No. E–115–
2013/0 ‘‘Encircling Suture Delivery
System For Flexible Circumferential
Suture,’’ U.S. Provisional Patent
Application 61/834,357 filed June 12,
2013, International Patent Application
PCT/US2014/040716 filed under the
Patent Cooperation Treaty on June 3,
2014, European Patent Application
14735030.0 having an international
filing date of June 3, 2014 and U.S.
Patent Application 14/898,020 also
having an international filing date of
June 3, 2014. The patent rights in these
inventions have been assigned to the
Government of the United States of
America. The prospective exclusive
patent License territory may be
worldwide and a field of use limited to
valvular regurgitation.
The invention embodied in NIH Ref.
No. E–027–2013/0 relates to devices and
methods for treating functional
tricuspid valve regurgitation and related
conditions. The devices are adapted for
applying force to an area of a patient’s
heart along or near the atrioventricular
groove and can include a tensioning
element configured to be delivered by a
flexible member guided through a
catheter and positioned generally along
or near the atrioventricular groove, and
a compression member that can be
positioned along the tensioning element
and over a desired segment of the
atrioventricular groove to develop force
to be applied to an adjacent area of the
heart by selective tensioning of the
tensioning element.
The invention embodied in NIH Ref
No. E–115–2013/0 relates to devices for
delivering encircling implants that can
include two separate limbs held
together at a distal articulation by the
implant being delivered. The implant
can comprise a suture and/or a braided

E:\FR\FM\13OCN1.SGM

13OCN1